1. Home
  2. PRVA vs TMDX Comparison

PRVA vs TMDX Comparison

Compare PRVA & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Privia Health Group Inc.

PRVA

Privia Health Group Inc.

HOLD

Current Price

$20.48

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$67.64

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRVA
TMDX
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.2B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
PRVA
TMDX
Price
$20.48
$67.64
Analyst Decision
Buy
Buy
Analyst Count
12
9
Target Price
$31.17
$148.22
AVG Volume (30 Days)
915.5K
1.9M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
63.64
382.18
EPS
0.02
0.20
Revenue
$2,122,842,000.00
$605,494,000.00
Revenue This Year
$18.19
$24.25
Revenue Next Year
$10.72
$18.75
P/E Ratio
$1,040.00
$342.25
Revenue Growth
22.26
37.13
52 Week Low
$18.78
$60.11
52 Week High
$26.51
$156.00

Technical Indicators

Market Signals
Indicator
PRVA
TMDX
Relative Strength Index (RSI) 28.14 33.95
Support Level $19.53 $60.11
Resistance Level $24.09 $71.14
Average True Range (ATR) 0.65 3.63
MACD -0.27 1.63
Stochastic Oscillator 2.78 66.12

Price Performance

Historical Comparison
PRVA
TMDX

About PRVA Privia Health Group Inc.

Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: